1. Home
  2. LBRT vs IMVT Comparison

LBRT vs IMVT Comparison

Compare LBRT & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Energy Inc.

LBRT

Liberty Energy Inc.

N/A

Current Price

$29.40

Market Cap

4.9B

Sector

Energy

ML Signal

N/A

Logo Immunovant Inc.

IMVT

Immunovant Inc.

N/A

Current Price

$23.85

Market Cap

5.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LBRT
IMVT
Founded
2011
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.0B
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
LBRT
IMVT
Price
$29.40
$23.85
Analyst Decision
Buy
Buy
Analyst Count
12
9
Target Price
$24.00
$30.78
AVG Volume (30 Days)
3.3M
972.1K
Earning Date
04-15-2026
02-06-2026
Dividend Yield
1.15%
N/A
EPS Growth
N/A
N/A
EPS
0.89
N/A
Revenue
$4,006,116,000.00
N/A
Revenue This Year
$0.07
N/A
Revenue Next Year
$7.91
N/A
P/E Ratio
$35.37
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.50
$12.72
52 Week High
$32.40
$29.25

Technical Indicators

Market Signals
Indicator
LBRT
IMVT
Relative Strength Index (RSI) 55.71 40.22
Support Level $10.80 $21.74
Resistance Level N/A $24.63
Average True Range (ATR) 1.41 1.12
MACD -0.17 -0.24
Stochastic Oscillator 50.17 25.99

Price Performance

Historical Comparison
LBRT
IMVT

About LBRT Liberty Energy Inc.

Liberty Energy Inc is a integrated energy services and technology company focused on providing hydraulic fracturing services and related technologies to onshore oil and natural gas exploration and production (E&P) companies. The Company offers customers with hydraulic fracturing services, together with complementary services including wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods (including sand mine operations), and technologies to facilitate lower emission completions, thereby helping customers reduce emissions profile. The company provides services across USA and Canada.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

Share on Social Networks: